Koninklijke Philips N.V. NY Registry Shares - ADR

The total asset value of Koninklijke Philips N.V. NY Registry Shares - ADR stood at $ 2,256 Mln as on 31-Mar-23

The share price of Koninklijke Philips N.V. NY Registry Shares - ADR is $20.590000 (NYSE) as of 22-Sep-2023 16:10 EDT. Koninklijke Philips N.V. NY Registry Shares - ADR has given a return of -21.95% in the last 3 years.

Koninklijke Philips N.V. NY Registry Shares - ADR has a market capitalisation of $ 17,930 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.

The P/B ratio of Koninklijke Philips N.V. NY Registry Shares - ADR is 0.83 times as on 02-Jun-2023, a -0.79% premium to its peers’ median range of 4.02 times.

Since, TTM earnings of Koninklijke Philips N.V. NY Registry Shares - ADR is negative, P/E ratio is not available.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Koninklijke Philips N.V. NY Registry Shares - ADR and enter the required number of quantities and click on buy to purchase the shares of Koninklijke Philips N.V. NY Registry Shares - ADR.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

The CEO & director of Dr. Paulus A. Stoffels M.D., Ph.D.. is Koninklijke Philips N.V. NY Registry Shares - ADR, and CFO & Sr. VP is Mr. Abhijit Bhattacharya.

The promoters of Koninklijke Philips N.V. NY Registry Shares - ADR have pledged 0% of the total equity as on Dec-22.

Some of the close peers are:

No, TTM profit after tax of Koninklijke Philips N.V. NY Registry Shares - ADR was $-2,122 Mln.